US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 23.820
  • +0.220+0.93%
Close Nov 8 16:00 ET
  • 23.820
  • 0.0000.00%
Post 16:00 ET
1.30BMarket Cap-17990P/E (TTM)

Bicara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--203.86M
5,442.09%230.44M
--230.44M
--4.16M
-Cash and cash equivalents
--203.86M
5,442.09%230.44M
--230.44M
--4.16M
Other current assets
--2.22M
-23.37%633K
--633K
--826K
Total current assets
--206.08M
4,536.30%231.07M
--231.07M
--4.98M
Non current assets
Net PPE
--619K
28.14%815K
--815K
--636K
-Gross PPE
--619K
28.14%815K
--815K
--636K
Other non current assets
--2.09M
93.35%2.09M
--2.09M
--1.08M
Total non current assets
--2.71M
69.23%2.91M
--2.91M
--1.72M
Total assets
--208.78M
3,390.71%233.98M
--233.98M
--6.7M
Liabilities
Current liabilities
Payables
--4.68M
-37.98%3.19M
--3.19M
--5.14M
-accounts payable
--4.68M
-37.98%3.19M
--3.19M
--5.14M
Current accrued expenses
--9.97M
-43.85%9.87M
--9.87M
--17.58M
Current debt and capital lease obligation
--300K
--285K
--285K
----
-Current capital lease obligation
--300K
--285K
--285K
--0
Current liabilities
--16.07M
-36.87%15.09M
--15.09M
--23.9M
Non current liabilities
Long term debt and capital lease obligation
--217K
--372K
--372K
--0
-Long term capital lease obligation
--217K
--372K
--372K
--0
Preferred securities outside stock equity
--367.28M
350.51%367.28M
--367.28M
--81.53M
Other non current liabilities
----
-80.00%17K
--17K
--85K
Total non current liabilities
--367.49M
350.52%367.67M
--367.67M
--81.61M
Total liabilities
--383.56M
262.78%382.75M
--382.75M
--105.51M
Shareholders'equity
Share capital
--2K
0.00%2K
--2K
--2K
-common stock
--2K
0.00%2K
--2K
--2K
Retained earnings
---182.58M
-51.45%-153.02M
---153.02M
---101.04M
Paid-in capital
--7.8M
90.50%4.25M
--4.25M
--2.23M
Total stockholders'equity
---174.78M
-50.57%-148.77M
---148.77M
---98.8M
Total equity
---174.78M
-50.57%-148.77M
---148.77M
---98.8M
Currency Unit
USD
USD
USD
USD
(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --203.86M5,442.09%230.44M--230.44M--4.16M
-Cash and cash equivalents --203.86M5,442.09%230.44M--230.44M--4.16M
Other current assets --2.22M-23.37%633K--633K--826K
Total current assets --206.08M4,536.30%231.07M--231.07M--4.98M
Non current assets
Net PPE --619K28.14%815K--815K--636K
-Gross PPE --619K28.14%815K--815K--636K
Other non current assets --2.09M93.35%2.09M--2.09M--1.08M
Total non current assets --2.71M69.23%2.91M--2.91M--1.72M
Total assets --208.78M3,390.71%233.98M--233.98M--6.7M
Liabilities
Current liabilities
Payables --4.68M-37.98%3.19M--3.19M--5.14M
-accounts payable --4.68M-37.98%3.19M--3.19M--5.14M
Current accrued expenses --9.97M-43.85%9.87M--9.87M--17.58M
Current debt and capital lease obligation --300K--285K--285K----
-Current capital lease obligation --300K--285K--285K--0
Current liabilities --16.07M-36.87%15.09M--15.09M--23.9M
Non current liabilities
Long term debt and capital lease obligation --217K--372K--372K--0
-Long term capital lease obligation --217K--372K--372K--0
Preferred securities outside stock equity --367.28M350.51%367.28M--367.28M--81.53M
Other non current liabilities -----80.00%17K--17K--85K
Total non current liabilities --367.49M350.52%367.67M--367.67M--81.61M
Total liabilities --383.56M262.78%382.75M--382.75M--105.51M
Shareholders'equity
Share capital --2K0.00%2K--2K--2K
-common stock --2K0.00%2K--2K--2K
Retained earnings ---182.58M-51.45%-153.02M---153.02M---101.04M
Paid-in capital --7.8M90.50%4.25M--4.25M--2.23M
Total stockholders'equity ---174.78M-50.57%-148.77M---148.77M---98.8M
Total equity ---174.78M-50.57%-148.77M---148.77M---98.8M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+2.26%